Literature DB >> 21080871

Tumour expression of lymphangiogenic growth factors but not lymphatic vessel density is implicated in human cervical cancer progression.

Nikolia Sotiropoulou1, Vasiliki Bravou, Sofia Kounelis, Vasileia Damaskou, Eirini Papaspirou, Helen Papadaki.   

Abstract

AIMS: The aim of the study was to investigate the role of lymphangiogenesis in human cervical cancer progression.
METHODS: The expression of VEGF-C, VEGF-D, VEGFR-3, podoplanin (D2-40), LYVE-1 and Prox-1 was studied by immunohistochemistry in 72 cases of invasive squamous cell carcinoma of the uterine cervix. For lymphatic endothelial markers lymphatic vessel density (LVD) was assessed. Correlations with lymphatic vessel invasion, nodal metastases, tumour grade, FIGO stage, and inflammation were also evaluated.
RESULTS: VEGF-D expression significantly correlated with lymph node metastasis, lymphatic emboli and FIGO stage as well as with peritumoural LVD. A marginally significant correlation was also found between the expression of VEGF-C and prognostic parameters. Lymphatic tumour emboli were successfully identified using D2-40 immunohistochemistry and peritumoural D2-40 LVD significantly correlated with lymphatic vessel invasion. However, LVD as assessed by multiple lymphatic markers was not associated with lymphatic metastasis. There was a significant correlation of Prox-1 and LYVE-1 LVD with the inflammatory stromal reaction.
CONCLUSIONS: Although LVD as assessed by multiple lymphatic markers was not correlated with prognostic parameters, tumour expression of lymphangiogenic growth factors seems to be critically implicated in lymphatic metastasis and cervical carcinoma progression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21080871     DOI: 10.3109/00313025.2010.522174

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  9 in total

Review 1.  TRPM8: a potential target for cancer treatment.

Authors:  Zhaoguo Liu; Hongyan Wu; Zhonghong Wei; Xu Wang; Peiliang Shen; Siliang Wang; Aiyun Wang; Wenxing Chen; Yin Lu
Journal:  J Cancer Res Clin Oncol       Date:  2016-01-23       Impact factor: 4.553

2.  Whole slide quantification of stromal lymphatic vessel distribution and peritumoral lymphatic vessel density in early invasive cervical cancer: a method description.

Authors:  C Balsat; S Blacher; N Signolle; A Beliard; C Munaut; F Goffin; A Noel; J M Foidart; F Kridelka
Journal:  ISRN Obstet Gynecol       Date:  2011-08-25

3.  Inferring models of multiscale copy number evolution for single-tumor phylogenetics.

Authors:  Salim Akhter Chowdhury; E Michael Gertz; Darawalee Wangsa; Kerstin Heselmeyer-Haddad; Thomas Ried; Alejandro A Schäffer; Russell Schwartz
Journal:  Bioinformatics       Date:  2015-06-15       Impact factor: 6.937

4.  Elevated VEGF-D Modulates Tumor Inflammation and Reduces the Growth of Carcinogen-Induced Skin Tumors.

Authors:  Hanne-Kaisa Honkanen; Valerio Izzi; Tiina Petäistö; Tanja Holopainen; Vanessa Harjunen; Taina Pihlajaniemi; Kari Alitalo; Ritva Heljasvaara
Journal:  Neoplasia       Date:  2016-07       Impact factor: 5.715

5.  Correlation of Vascular Endothelial Growth Factor subtypes and their receptors with melanoma progression: A next-generation Tissue Microarray (ngTMA) automated analysis.

Authors:  S Morteza Seyed Jafari; Christina Wiedmer; Simone Cazzaniga; Živa Frangež; Maziar Shafighi; Helmut Beltraminelli; Benedikt Weber; Hans-Uwe Simon; Robert E Hunger
Journal:  PLoS One       Date:  2018-11-08       Impact factor: 3.240

6.  Lymph Node Involvement in Early-Stage Cervical Cancer: Is Lymphangiogenesis a Risk Factor? Results from the MICROCOL Study.

Authors:  Matteo Tantari; Stefano Bogliolo; Matteo Morotti; Vincent Balaya; Florent Bouttitie; Annie Buenerd; Laurent Magaud; Fabrice Lecuru; Benedetta Guani; Patrice Mathevet
Journal:  Cancers (Basel)       Date:  2022-01-02       Impact factor: 6.639

Review 7.  The Role of PROX1 in Neoplasia: A Key Player Often Overlooked.

Authors:  Evangelia Ntikoudi; Alexandros Pergaris; Stylianos Kykalos; Ekaterini Politi; Stamatios Theocharis
Journal:  Diagnostics (Basel)       Date:  2022-07-04

8.  Lymphangiogenesis in cervical cancer evaluated by expression of the VEGF-C gene in clinical stage IB-IIIB.

Authors:  Magdalena Franc; Agata Kachel-Flis; Bogdan Michalski; Anna Fila-Daniłow; Urszula Mazurek; Mateusz Michalski; Anna Michalska; Ilona Kuczerawy; Violetta Skrzypulec-Plinta
Journal:  Prz Menopauzalny       Date:  2015-06-22

9.  Role and importance of the expression of transcription factor FOXC2 in cervical cancer.

Authors:  Jing Wang; Xiujuan Yue
Journal:  Oncol Lett       Date:  2017-09-20       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.